Browsing Tag
NASDAQ
800 posts
People Inc added 320 employees this year. Why is it still cutting 195 jobs?
People Inc is eliminating 195 positions, roughly 6% of its workforce, with most reductions concentrated in print and legacy web operations even after hiring 320 employees during 2026. The restructuring exposes a deeper media-economics shift as digital revenue grows but Google AI Overviews reduce search-driven traffic, forcing publishers to redirect people and investment toward commerce, licensing, social video and other businesses less dependent on conventional web visits.
November 1, 2026
Aspen Neuroscience (ASPE) prices $140.6m IPO at $15 as Parkinson’s therapy enters pivotal development phase
Aspen Neuroscience has priced its Nasdaq initial public offering at $15 per share, the bottom of its proposed range, as it prepares to advance the investigational Parkinson's disease cell therapy sasineprocel into Phase 3 testing. The financing extends the company's expected operating runway into the second half of 2028, but its clinical programme remains expensive, and the company expects to require additional capital before development is complete.
November 1, 2026
LENZ Therapeutics (NASDAQ: LENZ) cuts 75% of jobs after VIZZ Q3 sales reach $2.6m
LENZ Therapeutics is cutting three-quarters of its workforce and changing CEOs despite accelerating VIZZ prescriptions, betting that a much smaller organisation can market its new presbyopia drug more efficiently.
October 31, 2026
Dropbox (NASDAQ: DBX) cuts 9% of jobs and loses CTO as AI product strategy sharpens
Dropbox is cutting 9% of its global workforce and technology chief Ali Dasdan is leaving as management concentrates investment around its core product and Dash intelligence strategy.
October 31, 2026
AstraZeneca has 180 pipeline projects. Why is it cutting costs while investing more in R&D?
AstraZeneca is launching a three-year programme targeting about $1.5 billion of annual savings, with some roles expected to disappear even as the pharmaceutical group reinvests most of the benefit into a rapidly expanding pipeline.
October 31, 2026
Alphabet loses nearly $500bn in market value as AI spending and weaker search advertising alarm investors
Alphabet's shares have suffered a historic selloff after its third-quarter results exposed the financial strain of accelerating AI investment, negative free cash flow and softer-than-expected search advertising.
October 31, 2026
EnerSys bets $320m on Ultralife’s military batteries and drone power systems as defence demand grows
EnerSys has agreed to acquire Ultralife for approximately $320 million in enterprise value, offering shareholders $16 per share in cash. The transaction will expand EnerSys's position in military batteries, unmanned systems and specialized power technologies, with management targeting $15 million to $20 million in annual cost synergies and adjusted earnings accretion within approximately 18 months of closing.
October 29, 2026
Alphabet (NASDAQ: GOOGL) crashes after hours despite 103% Google Cloud growth as AI spending overwhelms cash flow
Alphabet delivered 25% quarterly revenue growth and more than doubled Google Cloud sales, but a $9.1 billion free cash flow deficit, investment valuation losses and weaker-than-expected advertising revenue triggered a sharp after-hours sell-off.
October 29, 2026
First Solar (FSLR) opens $330 million South Carolina facility as U.S. solar manufacturing strategy expands
First Solar is inaugurating the first phase of its approximately $330 million South Carolina production facility, which completes manufacturing processes for Series 6 Plus solar modules. The Gaffney operation currently employs about 500 people, with nearly 700 positions expected by mid-2027 as First Solar expands its American industrial footprint and adjusts its global supply chain.
October 29, 2026
Meta launches $35bn equity offerings within $95bn AI funding plan as cash flow turns negative
Meta Platforms has launched common and mandatory convertible preferred stock offerings as part of a wider financing strategy that could ultimately reach $95 billion. The plan reflects the rising cost of AI infrastructure and increasing pressure on cash flow, but proposed future share sales should not be mistaken for funding already secured.
October 28, 2026